The emerging treatment of this peptide represents a exciting development in the care of the condition. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide198210.blogprodesign.com/63455091/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment